ESTRO 2024 - Abstract Book

S3920

Physics - Image acquisition and processing

ESTRO 2024

2. Singh J, Greer PB, White MA, et al. Treatment-related morbidity in prostate cancer: a comparison of 3-dimensional conformal radiation therapy with and without image guidance using implanted fiducial markers. Int J Radiat Oncol Biol Phys. 2013;85(4):1018-023. Doi:10.1016/j.ijrobp.2012.07.2376

3. Dang A, Kupelian PA, Cao M, Agazaryan N, Kishan AU. Image-guided radiotherapy for prostate cancer. Transl Androl Urol. 2018;7(3):308-320. Doi:10.21037/tau.2017.12.37

4. Johnson LM, Turkbey B, Figg WD, Choyke PL. Multiparametric MRI in prostate cancer management. Nat Rev Clin Oncol. 2014;11(6):346-353. doi:10.1038/nrclinonc.2014.69

5. Maurer MH, Heverhagen JT. Diffusion weighted imaging of the prostate-principles, application, and advances. Transl Androl Urol. 2017;6(3):490-498. doi:10.21037/tau.2017.05.06

6. Kerkmeijer LGW, Groen VH, Pos FJ, et al. Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial. J Clin Oncol. 2021;39(7):787-796. doi:10.1200/JCO.20.02873 7. Sokmen BK, Sokmen D, Ucar N, Ozkurt H, Simsek A. The correlation between biological activity and diffusion weighted MR imaging and ADC value in cases with prostate cancer. Arch Ital Urol Androl. 2017;89(4):277-281. Published 2017 Dec 31. Doi:10.4081/aiua.2017.4.277 8. Manetta R, Palumbo P, Gianneramo C, et al. Correlation between ADC values and Gleason score in evaluation of prostate cancer: multicentre experience and review of the literature. Gland Surg. 2019;8(Suppl 3):S216-S222. Doi:10.21037/gs.2019.05.02

9. Hargreaves BA, Worters PW, Pauly KB, Pauly JM, Koch KM, Gold GE. Metal-induced artifacts in MRI. AJR Am J Roentgenol. 2011;197(3):547-555. doi:10.2214/AJR.11.7364

10. McRobbie DW, Moore EA, Graves MJ. MRI from Picture to Proton. 2nd ed. Cambridge University Press; 2007.

2432

Digital Poster

Intracranial MRI-CT registration uncertainties: a motivation for MRI-only radiotherapy or not?

Minna Lerner 1,2 , Joakim Medin 1,3 , Sara Alkner 4,5 , Lars E Olsson 2,1 , Emilia Persson 1,2

1 Radiation Physics, Department of Hematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund, Sweden. 2 Medical Radiation Physics, Department of Translational Medicine, Lund University, Malmö, Sweden. 3 Department of Medical Radiation Physics, Clinical Sciences, Lund University, Lund, Sweden. 4 Clinic of Oncology, Department of Hematology, Oncology, and Radiation Physics, Skåne University Hospital, Lund, Sweden. 5 Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, Lund, Sweden

Purpose/Objective: